Document is current
Any future updates will be listed below
-
Authors
Ogdie, Alexis http://orcid.org/0000-0002-4639-0775
Nowell, W. Benjamin
Applegate, Eddie
Gavigan, Kelly
Venkatachalam, Shilpa
de la Cruz, Marie
Flood, Emuella
Schwartz, Ethan J.
Romero, Beverly
Hur, Peter
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (N/A)
- License Information
-
More Information
Article History
Received: 28 May 2019
Accepted: 30 October 2019
First Online: 10 January 2020
Ethics approval and consent to participate
: Our study has been reviewed and approved by a central institutional review board (IRB; Salus IRB). All research was conducted in compliance with the Declaration of Helsinki of 1964 and all later amendments. All participants were required to provide verbal and electronic consent prior to participating.
: Not applicable.
: A. Ogdie has received consulting fees from AbbVie, Amgen, BMS, Celgene, Lilly, Novartis, Pfizer, and Takeda, and has received grant support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatology Research Foundation, Pfizer, and Novartis. W. B. Nowell, K. Gavigan, and S. Venkatachalam are employees of Global Healthy Living Foundation. E. Applegate is a patient advocate affiliated with Global Healthy Living Foundation. M. de la Cruz, B. Romero, and E. Schwartz are employees of ICON, which was contracted by Novartis to conduct the study; E. Flood was an employee of ICON at the time of the analysis. P. Hur is an employee of Novartis Pharmaceuticals Corporation.
